0001415889-24-010567.txt : 20240409 0001415889-24-010567.hdr.sgml : 20240409 20240409161900 ACCESSION NUMBER: 0001415889-24-010567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240405 FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NELSON TIMOTHY S CENTRAL INDEX KEY: 0001244229 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40353 FILM NUMBER: 24832957 MAIL ADDRESS: STREET 1: 1024 BUBB ROAD CITY: CUPERTINO STATE: CA ZIP: 950144166 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IPI Legacy Liquidation Co CENTRAL INDEX KEY: 0001445499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 0426 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 FORMER COMPANY: FORMER CONFORMED NAME: IMPEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20220425 FORMER COMPANY: FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC DATE OF NAME CHANGE: 20080917 4 1 form4-04092024_080445.xml X0508 4 2024-04-05 1 0001445499 IPI Legacy Liquidation Co IMPLQ 0001244229 NELSON TIMOTHY S C/O IMPEL PHARMACEUTICALS INC. 201 ELLIOTT AVE. W, STE 260 SEATTLE WA 98119 true false false false 0 Common Stock 2024-04-05 4 J 0 10000 0 D 0 D Stock Option (right to buy) 1.97 2024-04-05 4 J 0 12303 0 D 2027-02-13 Common Stock 12303 0 D Stock Option (right to buy) 2.46 2024-04-05 4 J 0 3053 0 D 2028-03-08 Common Stock 3053 0 D Stock Option (right to buy) 2.95 2024-04-05 4 J 0 22325 0 D 2029-02-07 Common Stock 22325 0 D Stock Option (right to buy) 9.96 2024-04-05 4 J 0 11500 0 D 2031-07-10 Common Stock 11500 0 D Stock Option (right to buy) 8.65 2024-04-05 4 J 0 12789 0 D 2032-06-15 Common Stock 12789 0 D Stock Option (right to buy) 1.34 2024-04-05 4 J 0 13222 0 D 2033-06-15 Common Stock 13222 0 D Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery. The option was fully vested. The option was scheduled to vest in full as of June 16, 2024. /s/ Timothy S. Nelson 2024-04-09